FamilieSCN2A Foundation Press Releases

• Published on February 24, 2025 - 17:00 GMT

  

  FamilieSCN2A and Cellectricon Partner to Accelerate Drug Development for a Top Autism and Epilepsy Gene, SCN2A

  Powerful new partnership to lead to faster cures for SCN2A-related disorders GETTYSBURG, PA, UNITED STATES, February 24, 2025 /⁨EINPresswire.com⁩/ -- The FamilieSCN2A Foundation, the leading nonprofit organization in the world dedicated to improving the …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on February 24, 2025 - 14:00 GMT

  

  FamilieSCN2A Foundation Expands Multidisciplinary Care with Children's Hospital Colorado Neurogenetics Clinic

  One-stop, comprehensive clinical care for SCN2A-related disorders eases patients' burden and contributes to accelerating research. DENVER, CO, UNITED STATES, February 24, 2025 /⁨EINPresswire.com⁩/ -- The FamilieSCN2A is excited to announce a new …

  Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
• Published on August 26, 2024 - 16:29 GMT

  

  FamilieSCN2A Foundation Announces Recipients of the 2024 Action Potential Awards

  Megan Abbot, MD, of Children’s Hospital Colorado and Kathryn Salvati, PhD, of UCSF Each Receive $75,000 SCN2A Research Grants GETTYSBURG, PENNSYLVANIA, UNITED STATES, August 26, 2024 /⁨EINPresswire.com⁩/ -- The FamilieSCN2A Foundation, the leading …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on April 26, 2024 - 16:00 GMT

  

  New Study in Journal, Brain, Reveals Expanded Clinical Phenotype Spectrum in SCN2A-related disorders

  GETTYSBURG, PA, UNITED STATES, April 26, 2024 /⁨EINPresswire.com⁩/ -- A groundbreaking study newly published in Brain, "Expanded clinical phenotype spectrum correlates with variant function in SCN2A-related disorders," sheds a deeper light on how …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on March 7, 2024 - 15:33 GMT

  

  FamilieSCN2A Foundation Partners with NORD® to Initiate Registry for SCN2A-related disorders

  Global research study plans to accelerate treatments for SCN2A-related disorders, a rare disease associated with epilepsy, intellectual disability, and autism. GETTYSBURG, PA, UNITED STATES, March 7, 2024 /⁨EINPresswire.com⁩/ -- The FamilieSCN2A …

  Distribution channels: Banking, Finance & Investment Industry, Culture, Society & Lifestyle ...
• Published on February 29, 2024 - 14:00 GMT

  

  FamilieSCN2A Foundation Partners with UTHealth Houston on First Multidisciplinary Center for SCN2A-Related Disorders

  Forging a Path Towards a Brighter Future HOUSTON, TX, UNITED STATES, February 29, 2024 /⁨EINPresswire.com⁩/ -- SCN2A-related disorders are a spectrum of devastating neurological conditions that initially present in very early childhood and include …

  Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
• Published on October 11, 2023 - 16:40 GMT

  

  FamilieSCN2A Foundation Announces Third Hodgkin-Huxley Funding Award of 2023 to Danish Researcher Rikke Møller, PhD

  Dr. Rikke Møller, Professor of Epilepsy Genetics Filadelfia University, will receive $38,243 to establish and maintain an international SCN2A database. GETTYSBURG, PA, UNITED STATES, October 11, 2023 /⁨EINPresswire.com⁩/ -- The FamilieSCN2A Foundation, …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
• Published on September 13, 2023 - 13:00 GMT

  

  FamilieSCN2A Foundation Awards Prestigious Hodgkin-Huxley Grant to Dr. Kevin Bender to Advance SCN2A Therapeutic Metrics

  Dr. Bender will receive $334,390 to further his research. This grant will act as a catalyst towards our vision of treatments and cures for all SRDs. GETTYSBURG, PA, UNITED STATES, September 13, 2023 /⁨EINPresswire.com⁩/ -- The FamilieSCN2A Foundation, the …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
• Published on February 24, 2022 - 19:00 GMT

  

  Massachusetts Becomes One Of The First States to Proclaim February 24th as SCN2A Awareness Day

  The FamilieSCN2A Foundation Announces Massachusetts Recognizing February 24th as SCN2A Awareness Day BOSTON, MA, UNITED STATES, February 24, 2022 /⁨EINPresswire.com⁩/ -- The FamilieSCN2A Foundation, a nonprofit organization established to improve the …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Politics ...
• Published on February 24, 2022 - 14:00 GMT

  

  The FamilieSCN2A Foundation Announces The First Three (3) States Recognizing February 24th as SCN2A Awareness Day

  The FamilieSCN2A Foundation announces proclamations received from three (3) US states: CA, MA, and PA declaring February 24th SCN2A Awareness Day. UNITED STATES, February 24, 2022 /⁨EINPresswire.com⁩/ -- The FamilieSCN2A Foundation, a nonprofit …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 24, 2022 - 01:02 GMT

  

  Pennsylvania Becomes One Of The First States to Proclaim Feb 24th as SCN2A Awareness Day

  The FamilieSCN2A Foundation Announces Pennsylvania State House of Representatives Citation proclaiming February 24 as Pennsylvania’s SCN2A Awareness Day. HARRISBURG, PA, UNITED STATES, February 23, 2022 /⁨EINPresswire.com⁩/ -- The FamilieSCN2A Foundation, …

  Distribution channels: Business & Economy, Companies ...